Pillstats
Rx only · Tablet, Extended Release · Oral

Desvenlafaxine

Desvenlafaxine Succinate

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US29 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers11 labelers
Packages76
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 20 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.224$0.449$0.673$0.897Dec 2025Apr 2026Jul 2026
$0.758
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
11
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

36K72K108K144K2025 Q12025 Q22025 Q32025 Q42026 Q1
125K
Rx · 2026 Q1
4.8M
Units dispensed
+41%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it11 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager26SUPPLYING
Advagen Pharma Ltdunknown12SUPPLYING
Marlex Pharmaceuticals Incunknown8SUPPLYING
Slate Run Pharmaceuticals, LLCunknown5SUPPLYING
A-S Medication Solutionsunknown5SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown4SUPPLYING
NorthStar Rx LLCunknown4SUPPLYING
Preferred Pharmaceuticals Inc.unknown4SUPPLYING
Alembic Pharmaceuticals Limitedunknown4SUPPLYING
Actavis Pharma, Inc.unknown3SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 15, 2021
    RECALLRecall (Class II): Desvenlafaxine Extended-Release Tablets 25 mg 30 Tablets Rx Only NDC 0591-4060-30 Manufactured by: Actavis Laboratories…

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC